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Abstract
Objective: The aim of the study was to propose an efficient chairside clinical strategy
for the identification of undiagnosed hyperglycaemia in periodontal clinics.
Material and methods: Α chairside system was used for assessment of glycated
hemoglobin 1c (HbA1c) and active Matrix Metalloproteinase-8 levels (aMMP-8) were
analyzed by immunotest in patients (n = 150) who fulfilled the criteria for screening
of the Centers for Disease Control and Prevention. Full-mouth periodontal para-
meters were assessed and various data such as Body Mass Index (BMI), smoking and
education were recorded.
Results: Thirty-one patients out of 150 tested were found with unknown hyperglycaemia
(20.7%). Regarding sex, education, parent with diabetes, normal BMI, smoking, age
≥45 years and prior testing for diabetes, no differences were observed between subjects
displaying HbA1c < 5.7 and ≥5.7% (Pearson's Chi-square test, p > .05). Subgroups
differed regarding BMI (kg/m2), tooth count, percentages of 4 and 5 mm pockets (Mann–
Whitney and z-test, p < .05). The diagnostic performance for HbA1c ≥5.7 was tested by
Receiving Operator Characteristic curves and Areas Under the Curve (AUC) for the
following: age ≥ 45 years and BMI (AUC 0.651, p = .010), the above and aMMP-8 (AUC
0.660, p = .006), age ≥ 45 years, BMI and Stage of Periodontitis (AUC 0.711, p < .001)
and age ≥ 45 years, BMI, aMMP-8 and stage of periodontitis (AUC 0.713, p < .001).
Conclusions: Findings of the study suggest that the combination of stage of peri-
odontitis, increasing age, BMI and aMMP-8, without chairside HbA1c assessment
appears to be a viable screening strategy for referring dental patients for testing for
prediabetes/diabetes.
K E YWORD S
diabetes, diagnosis, matrix metalloproteinase
1 | INTRODUCTION
Type 2 diabetes mellitus (DMT2) has become a global pandemic, lead-
ing to significant morbidity, mortality and financial healthcare issues
(A.D.A., 2020). It has been estimated that 425 millions of individuals
(20–79 years old) worldwide had diabetes in 2017 and this number is
expected to rise into 629 millions by the year 2045 (Ogurtsova
et al., 2017). Type 2 diabetes is often unrecognized, as it is
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asymptomatic during the initial stage of the disease. The global per-
centage of undiagnosed diabetes is alarming, and estimated to be
212.4 millions of adults in 2017, mainly from low and middle income
countries (Cho et al., 2018). Prediabetes, defined as hyperglycaemia
which is below the pathologic threshold but very close to it [Glycated
hemoglobin 1c (HbA1c) 5.7–6.4%, and/or fasting plasma glucose
(FPG) 100 mg/dL to 125 mg/dL] almost always precedes type 2 diabetes
(C.D.C., 2017). However, as it has been solidly shown by randomized
controlled clinical trials, lifestyle interventions are effective in preventing
the progression of prediabetes to diabetes (Baker, Simpson, Lloyd,
Bauman, & Singh, 2011; Howells, Musaddaq, McKay, & Majeed, 2016).
Given the above-mentioned facts, early detection and timely
intervention especially regarding the stage of prediabetes are of cardi-
nal importance. Several studies have already investigated the effec-
tiveness of diabetes screening in dental settings, applying various
methods of patient selection and identification of hyperglycaemia
(Barasch et al., 2012; Bossart et al., 2016; Franck, Stolberg, Bilich, &
Payne, 2014; Genco et al., 2014; Grigoriadis et al., 2019; Herman,
Taylor, Jacobson, Burke, & Brown, 2015; Holm et al., 2016; Lalla,
Cheng, Kunzel, Burkett, & Lamster, 2013; Lalla, Kunzel, Burkett,
Cheng, & Lamster, 2011; Li, Williams, & Douglass, 2011; Rosedale &
Strauss, 2012; Strauss et al., 2010). Although these studies are hetero-
geneous with regards to criteria for patient selection and the tech-
nique applied for prediabetes/diabetes assessment, the general
conclusion is that early diagnosis of prediabetes/diabetes is feasible
by dentists, especially in periodontally compromised patients.
In parallel, periodontal pathology is known to upregulate
pro-inflammatory mediators such as tissue destructive matrix
metalloproteinases (MMPs) including neutrophil collagenase known as
collagenase-2 (MMP-8) in inflamed gingiva and oral fluids and an
effective chairside test for active MMP-8 and not the latent form is
available for clinical praxis (Grigoriadis et al., 2019; Rathnayake
et al., 2013; Ryan, Ramamurthy, Sorsa, & Golub, 1999; Safkan-Seppälä,
Sorsa, Tervahartiala, Beklen, & Konttinen, 2006; Sorsa et al., 1992;
Sorsa et al., 2020).
The aim of the present study is to propose a chairside point-of-
care (PoC) clinical strategy applied in patients attending periodontal
clinics for the identification of undiagnosed hyperglycaemia.
2 | MATERIALS AND METHODS
2.1 | Subject sample
The minimally required sample size for identifying subjects with
undiagnosed diabetes (n = 139) was calculated according to the
estimated percentage of undiagnosed diabetes in Europe (10%) and
by applying the relevant statistical equation as described before
(Mataftsi, Koukos, & Sakellari, 2019). Consecutive periodontal
patients who visited the Department of Periodontology, Dental
School, Aristotle University, Thessaloniki, Greece, and the Periodontal
Department of 424 General Army Hospital, Thessaloniki, Greece,
formed the sample pool of 731 possible participants. The self-
assessed questionnaire proposed by the CDC (Centres for Disease
Control and Prevention, USA) (“Centres for Disease Control and Pre-
vention. Prediabetes Screening Test. National Diabetes Prevention
Programme. Available at https://www.cdc.gov/diabetes/prevention/
pdf/prediabetestest.pdf,”) was used to identify 150 patients being at
high risk for developing diabetes mellitus (score > 9) and these sub-
jects were included in the study (Supplementary Table 1). Partici-
pants signed an informed consent and the study was conducted
according to the protocol outlined by the Research Committee, Aris-
totle University of Thessaloniki, Greece, and approved by the Ethical
Committee of the School of Dentistry (protocol number #64,
06/12/2018). All procedures performed in the present study involv-
ing human participants were in accordance with the ethical stan-
dards of the institutional and/or national research committee and
with the 1964 Helsinki declaration and its later amendments or com-
parable ethical standards.
2.2 | Clinical procedures
In subjects who fulfilled the CDC criteria for developing diabetes type
2, the Cobas® b101 (Roche Diagnostics, Hoffmann La Roche, Mann-
heim, Germany) in vitro diagnostic test system for determination of
HbA1c levels was applied. The system determines the amount of
HbA1c in human capillary blood by photometric transmission mea-
surement. The method has been standardized against the IFCC
(International Federation of Clinical Chemists) reference method
(Zhang et al., 2018). This diagnostic test also provides, at the same
time, values of free glucose, when HbA1c is above 4.9%.
After this assessment, patients were instructed to provide an oral
rinse in order to quantitate Matrix metalloproteinase (MMP)-8 (neu-
trophil collagenase-2) levels in its active form (aMMP-8) by the chair-
side/Point of Care (POC) PerioSafe® immunotest, combined by the
digital reader ORALyzer® according to the manufacturer's instruc-
tions (Dentognostics GmbH—Jena, Germany). It has been shown that
aMMP-8 levels >20 ng/mL are indicative of actual periodontal tissue
destruction (Räisänen et al., 2018; Räisänen et al., 2019; Sorsa
et al., 2016; Sorsa, Gieselmann, Arweiler, & Hernández, 2017) and
therefore were considered as a threshold for active proinflammatory
and tissue destructive events .
Several parameters including Body Mass Index (BMI), age, level of
education, and smoking were also recorded. Periodontal examination
included clinical measurement of Probing Depth (PD), Clinical Attach-
ment Level (CAL), Bleeding on Probing (BOP) and Plaque Levels in six
surfaces of each tooth, excluding third molars by using an automated
probe (Florida Probe, Florida Probe Corporation, Gainesville, FL, USA)
by one calibrated examiner (A.G.). All patients were classified by the
2018 classification of periodontal diseases (Papapanou et al., 2018).
All subjects identified with hyperglycaemia (HbA1c ≥ 5.7%) were
strongly advised to contact their physician for further consultation,
and laboratory tests. Participants were also asked about the ease and
convenience of the procedure and whether they would repeat it at
the dental clinic.
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2.3 | Statistical methods
Statistical analyses were performed with the SPSS Base 25.0. Statisti-
cal Software Package (SPSS Inc., IBM, Chicago, IL, USA). Data analysis
was performed, and figures plotted with statistical software. Patient
characteristics and their association with prediabetes and periodontal
condition were tested by Pearson's Chi-square test, Kruskal–Wallis
H test, Welch's t-test, and Mann–Whitney U test (Table 1). After a
significant Kruskal–Wallis H test, Dunn–Bonferroni test was used for
pairwise post hoc comparisons. Normality assumption for parametric
tests was assessed graphically with a histogram and a Q–Q plot, and
numerically with the Shapiro–Wilk test. All continuous variables
(in prediabetes and periodontal condition calculations) in Table 1 were
non-normal.
For clinical parameters, PD, CAL, BOP and Plaque Levels, indica-
tors of Descriptive Statistics were used, such as mean and SD for each
subgroup, with the patient as the observational unit. Differences in
clinical parameters were sought in subgroups formed by aMMP-8
<20 ng/mL and >20 ng/mL, and HbA1c <5.7 and ≥5.7 by applying the
Mann–Whitney U test (Table 2).
Firth's bias-reduced logistic regression was used for exploring the
association between the active MMP-8 (aMMP-8) point-of-care test
(ORALyzer®) and prediabetes, because there was a low prevalence
for many variables. This leads to so called complete separation, which
is a statistical challenge occurring when the dependent variable sepa-
rates one (or more than one) variable completely. As a result, the
estimates for the independent variables cannot be obtained, as the
maximum likelihood does not exist. A common approach to this prob-
lem is to use Firth's method with a penalized maximum likelihood esti-
mation (Heinze & Schemper, 2002). Receiver Operating Characteristic
(ROC) curves were created using logistic regression models calculated
by Firth's method and their predicted probabilities. The ROC curves
were analyzed by Youden's index (Youden, 1950) to find efficient
cut-off points for the models. Based on this cut-off and prediabetes
prevalence, models were compared according to their performance in
prediabetes diagnostics (Supplementary Table 2).
A two-sided p value <.05 was considered statistically significant
in this study.
3 | RESULTS
Thirty-one patients out of 150 tested were found to have
HbA1c ≥ 5.7% (20.7%), 24 of which had HbA1c 5.7–6.4%, indicating
undiagnosed prediabetes (16%), and seven displayed HbA1c ≥ 6.5%
(range 6.8–8.9%) indicating undiagnosed diabetes (4.7%). The
remaining participants (119 patients) had HbA1c < 5.7%.
Patients characteristics according to HbA1c levels and periodon-
tal condition are presented in Table 1. Regarding variables sex, educa-
tion, parent with diabetes, smoking, age ≥45 years and prior testing
for diabetes, no statistically significant differences were observed
between subjects displaying HbA1c levels <5.7 and ≥5.7 (Pearson's
Chi-square test, p > .05). In contrast, these subgroups differed regard-
ing BMI (kg/m2), tooth count, percentages of 4 mm and 5 mm
pockets, with subjects in the hyperglycaemia group exhibiting lower
number of teeth, and higher numbers of 4 and 5 mm pockets (Mann–
Whitney U test, p < .05). Also, a larger proportion of subjects with
HbA1c levels ≥5.7 exhibited Stage III periodontitis compared to peri-
odontally healthy individuals (p < .05 z-test with Bonferroni correction).
Parameters which statistically significantly affected the periodon-
tal condition of participants were sex, education, smoking, age
≥45 years and HbA1c levels ≥5.7 (Pearson's Chi-square test, p < .05),
while the tooth count decreased and number of pockets 4, 5 and
6 mm gradually increased according to the Stage of periodontitis
(Kruskal–Wallis H test, p < .001). Further, periodontally healthy
patients had significantly higher number of teeth compared to Stage I,
II and III patients (Dunn–Bonferroni test, p < .05, p < .001, p < .001,
respectively). Similarly, the number of 4 mm, 5 mm and 6 mm pocket
TABLE 2 Periodontal parameters in
investigated subgroups
PD (mm) CAL (mm) ΒOP Plaque
Mean ± SD Mean ± SD Mean ± SD Mean ± SD
HbA1c <5.7
[n = 119]
2.81 ± 0.78 3.18 ± 1.06 0.50 ± 0.24 0.47 ± 0.28
HbA1c ≥5.7
[n = 31]
3.20 ± 0.94 3.54 ± 1.20 0.62 ± 0.25 0.52 ± 0.27
aMMP-8 < 20
[n = 98]
2.68 ± 0.67 3.04 ± 0.97 0.49 ± 0.25 0.43 ± 0.25
aMMP-8 > 20
[n = 52]
3.30 ± 0.94 3,77 ± 1.17 0.60 ± 0.22 0.57 ± 0.29
HBA1c < 5.7&aMMP8 < 20
[n = 81]
2.63 ± 0.65 3.00 ± 0.99 0.47 ± 0.25 0.44 ± 0.26
HBA1c > 5.7&aMMP8 > 20
[n = 14]
3.57 ± 1.03 4.36 ± 1.19 0.69 ± 0.20 0.63 ± 0.25
Note: Differences between subgroups are indicated by bold lettering, Mann–Whitney test p < .05.
Abbreviations: aMMP-8: active matrix metalloproteinase −8; BOP: Bleeding on probing; CAL: clinical
attachment level; HBA1c: glycated hemoglobin A1c; PD: probing depth.
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counts were significantly different in all five pairwise comparisons
between healthy and Stage II and III (Dunn–Bonferroni test, p < .05),
but not between healthy and Stage I patients (Dunn–Bonferroni
test, p > .05).
Periodontal parameters and differences between subgroups are
depicted in Table 2.
Participants were stratified according to HbA1c levels, aMMP-8
levels above and below the threshold of 20 ng/mL and the combined
presence or not of both HbA1c levels ≥5.7 and aMMP-8 >20 ng/mL.
Subjects with HbA1c levels ≥5.7, aMMP-8 levels >20 ng/mL and the
combined presence of elevated levels exhibited statistically signifi-
cantly higher values of BOP, PD and CAL, compared to participants
with HbA1c levels <5.7, aMMP-8 levels <20 ng/mL and the combined
absence of elevated levels for these parameters respectively (Mann–
Whitney U test, p < .05). Plaque levels were significantly elevated in
the same groups except for HbA1c (Mann–Whitney U test, p < .05).
The diagnostic performance for HbA1c ≥ 5.7 was tested for a
number of parameters and their combinations with the calculated
optimal cut-offs (Figure 1 and Supplementary Table 2). In univariable
Firth's biased reduced logistic regression, aMMP-8 levels as measured
by ORALyzer, Periodontitis stage and BMI were significantly
associated with HbA1c ≥ 5.7 (p = .0497, p = .0012 and p = .0216,
respectively), while age ≥ 45 years was not.
ROC curves were constructed and Areas Under the Curve (AUC)
calculated for the following combinations: Model 1: age ≥ 45 years
and BMI, Model 2: age ≥ 45 years, BMI and aMMP-8 > 20 ng/mL,
Model 3: age ≥ 45 years, BMI and Stage of Periodontitis and finally
Model 4: age ≥ 45 years, BMI, aMMP-8 > 20 ng/mL and Stage of
Periodontitis. For base model, Model 1, AUC was 0.651 (p = .010),
while for Model 2 AUC was 0.660 (p = .006). Model 3 depicted AUC
0.711 (p < .001) and Model 4 AUC was .713 (p < 0.001).
All participants reported that the procedure was easy, convenient
and patient-friendly and that they would repeat it, if required.
4 | DISCUSSION
The present study demonstrates that performing a chairside HbA1c
measurement in the dental settings can depict subjects with
undiagnosed hyperglycaemia, since the screening strategy managed to
identify 24 patients (16% of the sample) with undiagnosed prediabetes
and seven patients (4.7% of the sample) with undiagnosed diabetes. Alto-
gether, subjects with previously undiagnosed hyperglycaemia were
20.7% of the 150 participants of the study. This fact allows for early
diagnosis of prediabetes/diabetes by referring these subjects to medical
doctors for further investigation. It is reminded that the above subject
sample consisted of individuals fulfilling the criteria for further screening
of the CDC (“Centres for Disease Control and Prevention [CDC]. Predia-
betes Screening Test. National Diabetes Prevention Programme. Avail-
able at https://www.cdc.gov/diabetes/prevention/pdf/prediabetestest.
pdf,”). In the absence of the feasibility of performing chairside HbA1c
assessment in the dental clinic, a Point-of-Care aMMP-8 mouth-rinse
test can improve the screening ability of validated questionnaires espe-
cially in periodontally diseased subjects.
According to the CDC, an estimated 33.9% of U.S. adults aged
18 years or older (84.1 million people) had prediabetes in 2015, based
on their fasting glucose or HbA1c levels, with adults aged 65 years
depicting prediabetes at an especially high percentage (48.3%)
(C.D.C., 2017). Among adults with prediabetes, 11.6% reported being
told by a health professional that they had this condition, while age-
adjusted data for 2011–2014 indicated that more men (36.6%) than
women (29.3%) had prediabetes and that prevalence of prediabetes
was similar among racial and ethnic groups. In the US alone, it was
estimated that USD 44 billion was spent on healthcare due to predia-
betes (Dall et al., 2014).
The prevalence of DMT2 in Greece remains high, and according
to recent data (Liatis et al., 2016) it accounts for 7.0% of the popula-
tion (with 8.2% prevalence of DMT2 for people ≥15 years of age). On
the other hand, prediabetes prevalence is not well studied, with some
estimates from regional studies raising it to around 22% of the adult
population (Makrilakis et al., 2011). Recently published data regarding
139 Greek subjects with periodontal disease who also fulfilled the
CDC criteria for screening and were chairside-assessed for HbA1c
with the Cobas® b101 system have shown that almost 25% of the
F IGURE 1 ROC curve for prediabetes (HbA1c) diagnostics based
on four Firth's bias-reduced logistic regression models built by
aMMP-8 levels measured by ORALyzer, Periodontitis stage
(PerioStage), and prediabetes risk factors BMI and Age ≥ 45 years.
Optimal cut-offs (Youden's index) on the ROC curves for each model
denoted by the triangles. ROC curve for prediabetes (HbA1c)
diagnostics based on four Firth's bias-reduced logistic regression
models built by aMMP-8 levels measured by ORALyzer, Periodontitis
stage (PerioStage), and prediabetes risk factors BMI and
Age ≥ 45 years. Optimal cut-offs (Youden's index) on the ROC curves
for each model denoted by the triangles
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subjects tested had unknown hyperglycaemia (Mataftsi et al., 2019).
In addition, subjects with HbA1c ≥ 5.7% displayed higher proportions
of sites with clinical attachment loss >5 mm. These findings suggested
that periodontal patients, especially those with bigger than normal
BMI and waist circumference, are a target group worth screening for
diabetes at the dental clinic (Mataftsi et al., 2019).
In the present study, participants were recruited irrelevant of
periodontal condition and the percentage of not previously known
hyperglycaemia was 20.7%. Both percentages are in agreement with
the estimates for prediabetes in Greece as reported in studies from
the medical field.
The recent consensus report of the joint workshop of the Inter-
national Diabetes Federation and the European Federation of
Periodontology reports that dentists dealing with patients without a
diagnosis of diabetes are encouraged to apply screening methods and
assess their risk for having diabetes, in order to refer to a physician
for further testing identified subjects (Sanz et al., 2018). In fact, the
importance of validated questionnaires has been shown in a number
of studies and they can be used with reasonable accuracy for prediabe-
tes/diabetes screening (Bang et al., 2009; Herman, Smith, Thompson,
Engelgau, & Aubert, 1995; Poltavskiy, Kim, & Bang, 2016; Rolka
et al., 2001). This approach is certainly low-cost and therefore suitable
for large-scale assessments both in clinical and community settings
especially in low income countries. However, albeit this well established
approach as shown in the current study according to model 1 (Figure 1),
it is suggested that in the absence of chairside assessment of glycated
hemoglobin A1c, an aMMP-8 chairside test could act—apart from peri-
odontal inflammation—as a surrogate marker in order to refer patients
for further evaluation by their physicians. This fact can contribute to
the overall worldwide effort to limit the “pandemic” of diabetes type
2 along with several studies investigating the possible participation of
dental practitioners to alert patients, by referring to medical practi-
tioners and resulting to an early diagnosis and/or treatment.
In fact, within the last years there are a number of studies investi-
gating the feasibility of diabetes screening in dental settings. In these
studies hyperglycaemia was identified either by chairside automated
analyzers or in collaboration with a laboratory (Baker et al., 2011;
Barasch et al., 2012; Bossart et al., 2016; Franck et al., 2014; Genco
et al., 2014; Grigoriadis et al., 2019; Herman et al., 2015; Holm et al.,
2016; Lalla et al., 2011; Lalla et al., 2013; Li et al., 2011; Rosedale &
Strauss, 2012; Strauss et al., 2010).
Although these studies vary significantly regarding their design,
sample size, age, racial and ethnic background of participants tested,
they all conclude that it is feasible to screen dental patients for diabe-
tes at the occasion of the dental visit (opportunistic screening). Note-
worthy, that it has been reported that patients tend to visit their
dentist on a more regular basis compared to their physician (Glick &
Greenberg, 2005). In the present study, HbA1c and aMMP-8 chairside
measurements were applied in patients attending periodontal clinics
who were in high risk of developing diabetes, according to the CDC
questionnaire, irrelevant of their periodontal condition (health or
inflammation). Since it is not clear which diagnostic laboratory or
chairside method is the most appropriate for identifying people with
prediabetes, in the current study we have chosen to apply HbA1c
assessment, a reliable test considered to reflect the state of blood
glucose levels over a time period (Sequeira & Poppitt, 2017) and more
convenient compared to FPG or oral glucose tolerance test since no
fasting is required (A.D.A., 2020). Known disadvantages of this
specific test include availability of test mainly in developed countries
(A.D.A., 2020) and the possibility of effects of ethnicity or hemoglobin
variants (Barry et al., 2017).
According to the findings and in agreement with the literature
subjects with HbA1c > 5.7 exhibited statistically significant differ-
ences in terms of clinical parameters of periodontal disease (Tables 1
and 2) thus underlying the contribution of hyperglycaemia to inflam-
mation of periodontal tissues. This fact was also shown, when
Periodontitis stage according to the 2018 classification (Papapanou
et al., 2018) was integrated in Receiver Operator Curves for diagnosing
hyperglycaemia (HbA1c ≥ 5.7%) either in combination with age ≥ 45 years
and BMI, or in combination with the above and aMMP-8 values
(ORALyzer®). In both cases as shown in Supplementary Table 2 and
Figure 1 the diagnostic performance for screening for prediabetes/
diabetes is quite satisfactory, especially when compared to using only
the known prediabetes/diabetes risk factors age ≥ 45 years and BMI.
In other words, both cases help to reduce the amount of false positive
findings and unnecessary referrals of patients to further prediabetes/
diabetes testings. Thus, increasing stage of periodontitis, increasing
age and splachnic obesity as well as elevated aMMP-8 levels in
mouth-rinse appear to be important factors for a periodontist to
encourage the patient for screening for diabetes. (Supplementary
Table 2, Figure 1). In the case of the POC aMMP-8 test, albeit its low
cost and convenience, it is surely not intended for massively screening
populations, but application at the dental office, especially for peri-
odontitis patients as shown in Figure 1, can strengthen the reasons
for a dentist to strongly recommend to a patient to get further
checked by a physician and receive recommended instructions/treat-
ment. It should be mentioned that this quantitative Point-of-Care test
is commercially available and in use for online and real-time diagnosis
and treatment monitoring of periodontitis (Alassiri et al., 2018;
Grigoriadis et al., 2019; Johnson et al., 2016; Lorenz et al., 2017;
Nwhator et al., 2014; Räisänen et al., 2018; Räisänen et al., 2019;
Raivisto, Sorsa, Räisänen, et al., 2020; Sorsa et al., 2017), while assess-
ment for HbA1c as applied in the present and other studies, is not yet
easily feasible for a dental practice. A recent systematic review has
shown that the dental workforce can be beneficially engaged in
screening for prediabetes/diabetes but further clinical trials are
required in order to optimize risk assessment protocols and strategies
(Yonel et al., 2020).
Besides, the incorporation of validated biomarkers will improve
diagnostic accuracy and assessment of stage and grade of the new
Periodontitis classification system by Tonetti et al (Tonetti, Greenwell,
& Kornman, 2018). and recent data have shown that the aMMP-8
mouth-rinse test can offer this possibility (Sorsa et al., 2020). This fact,
is corroborated by findings of the present study, since, as shown in
Table 2, the subgroup of participants with aMMP-8 above 20 ng/mL
displayed statistically significant differences in clinical parameters of
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periodontal disease compared to subjects with ORALyzer® values
below this threshold.
Taken collectively, findings of the present study suggest that the
combination of periodontitis, increasing age, BMI and aMMP-8, when
the use of chairside methods of HbA1c assessment is not available
appears to be a viable screening strategy for correctly referring dental
patients for further testing for prediabetes/diabetes by their physicians.
5 | CONCLUSIONS
In line with the previously published relevant reports, this study
provides further supporting and extending evidence that the periodontal
clinic is ideal for opportunistic screening for prediabetes/diabetes. Utili-
zation of point-of care technology, that is, mouth-rinse aMMP-8 PoC
assay enhances the ability of practitioners to contribute to the global
effort for early diagnosis of prediabetes and/or T2 diabetes mellitus.
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